NCT07815145 Quadroiliac Plane Block Versus Transmuscular Quadratus Lumborum Block for Postoperative Analgesia After Total Hip Arthroplasty
| NCT ID | NCT07815145 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Quadroiliac Plane Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-09-12 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-09-12 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate and compare the postoperative analgesic efficacy, opioid consumption, motor function preservation, and quality of recovery of ultrasound-guided Quadroiliac Plane Block (QIPB) versus transmuscular quadratus lumborum block (QLB) in patients undergoing THA under spinal anesthesia.
Eligibility Criteria
Inclusion Criteria: * Age 18-75 years. * Both sexes. * American Society of Anesthesiologists (ASA) classification I-III. * Scheduled for elective primary unilateral total hip arthroplasty under spinal anesthesia. Exclusion Criteria: * Allergy to local anesthetics. * Infection at the injection site. * Coagulopathy or bleeding disorders. * Neuromuscular disorders. * Chronic opioid use or dependence. * Body mass index (BMI) \> 40 kg/m². * Severe cardiac, hepatic, renal, or respiratory dysfunction. * Contraindication to regional anesthesia.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07815145 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Quadroiliac Plane Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07815145 currently recruiting?
Yes, NCT07815145 is actively recruiting participants. Contact the research team at mselsharkawy@med.tanta.edu.eg for enrollment information.
Where is the NCT07815145 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07815145 clinical trial?
NCT07815145 is sponsored by Tanta University. The trial plans to enroll 40 participants.